<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04855474</url>
  </required_header>
  <id_info>
    <org_study_id>IAAO-ETFM</org_study_id>
    <nct_id>NCT04855474</nct_id>
  </id_info>
  <brief_title>Protein Requirements in Male and Female Endurance Athletes</brief_title>
  <official_title>Estimating Post-exercise Protein Requirements in Male and Female Endurance Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protein is an essential macronutrient for post-exercise recovery through its ability to&#xD;
      provide the amino acid building blocks that support increased rates of muscle and whole body&#xD;
      protein synthesis.&#xD;
&#xD;
      Despite the growing understanding of the importance of post-exercise protein in endurance&#xD;
      athlete populations, the impact of sex and female menstrual cycle phase on protein metabolism&#xD;
      is not fully understood. To date, no studies have examined protein requirements in female&#xD;
      endurance trained athletes.&#xD;
&#xD;
      The aim of the proposed study is to utilize the well-established IAAO method to determine&#xD;
      protein requirements in endurance trained female and male athletes in a &quot;real-world&quot; and&#xD;
      at-home setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Eight men and eight women will be provided three different amino acid intakes on three separate occasions (metabolic trials) over 8 hours following a 20km run. All protein intakes have an amino acid composition modelled off of the profile of egg protein.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phenylalanine excretion</measure>
    <time_frame>8 hours</time_frame>
    <description>13CO2 production in umol/kg/h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phenylalanine Oxidation</measure>
    <time_frame>8 hours</time_frame>
    <description>[13C]phenylalanine oxidation in umol/kg/h</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phenylalanine net balance</measure>
    <time_frame>8 hours</time_frame>
    <description>Difference between phenylalanine rate of appearance and disappearance</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Urinary 3-methylhistidine</measure>
    <time_frame>8 hours</time_frame>
    <description>Concentration of urine 3-methylhistidine</description>
  </other_outcome>
  <other_outcome>
    <measure>Protein requirement</measure>
    <time_frame>8 hours</time_frame>
    <description>Estimated breakpoint of phenylalanine excretion, phenylalanine oxidation, and phenylalanine net balance</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Increased Metabolic Requirement</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Low Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.2 g/kg/day of protein provided as crystalline amino acid made after egg protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.2g/kg/day of protein provided as crystalline amino acid made after egg protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 g/kg/day of protein provided as crystalline amino acid made after egg protein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Amino Acid Intake</intervention_name>
    <description>Participants will consume hourly (8 hours) isoenergetic, isonitrogenous beverages containing one of the three protein intakes (0.2g/kg/d, 1.2 g/kg/d, 2.0g/kg/d) assigned in a randomized order between the three metabolic trials. Drinks will be enriched with stable isotope [13C]phenylalanine. The use of stable isotope [13C]phenylalanine will allow for the determination of the fate of AA in the body (incorporation into body protein or oxidation) which can be used to determine protein (AA) requirements.</description>
    <arm_group_label>High Protein</arm_group_label>
    <arm_group_label>Low Protein</arm_group_label>
    <arm_group_label>Moderate Protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy endurance trained runners. Total weekly running distance of greater than&#xD;
             50km/week and perform endurance exercise for more than 5 hours/week.&#xD;
&#xD;
          -  Age 18-35 years old&#xD;
&#xD;
          -  Eumenorrheic over last 3 months (one cycle no longer than 42 days and no shorter than&#xD;
             20 days).&#xD;
&#xD;
          -  Not using hormonal contraceptives (the pill, implants and injections, hormonal&#xD;
             intrauterine devices (IUDs), vaginal ring, skin patch).&#xD;
&#xD;
          -  Do not have polycystic ovarian syndrome (PCOS) or other conditions effecting ovarian&#xD;
             hormone regularity.&#xD;
&#xD;
          -  Not pregnant within the past year.&#xD;
&#xD;
          -  Must meet the classification of 'superior' aerobic power for their respective age&#xD;
             category based on the ACSM criteria; (women age 20-29 years VO2max &gt;50ml/kg/min and&#xD;
             women age 30-35 years VO2max &gt;46ml/kg/min) (men age 20-29 years VO2max &gt;56ml/kg/min&#xD;
             and men age 30-35 years VO2max &gt;54ml/kg/min).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to meet health and physical activity guidelines according to the CSEP 'Get&#xD;
             Active' Questionnaire (Appendix G).&#xD;
&#xD;
          -  Inability to adhere to study protocol requirements relating to diet and exercise (i.e.&#xD;
             alcohol and caffeine consumption, training/exercise prior to beginning a study testing&#xD;
             day).&#xD;
&#xD;
          -  Regular use of tobacco and/or other recreational drugs/banned substances (i.e. growth&#xD;
             hormone, testosterone, marijuana).&#xD;
&#xD;
          -  Self-reported intentional or unintentional weight loss (past 6 months) or plan to lose&#xD;
             weight (&gt;5-10kg).&#xD;
&#xD;
          -  Amenorrhea (self-reported) in the past 3 months.&#xD;
&#xD;
          -  Fewer than 6 menstrual cycles per year.&#xD;
&#xD;
          -  Answering yes to any questions asked within the COVID-19 screening questionnaire until&#xD;
             14 days of being symptom free and/or having a negative COVID-19 test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Moore, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Williamson</last_name>
    <phone>(416) 946-5620</phone>
    <email>eric.williamson@mail.utoronto.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Goldring Centre for High Performance Sport</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S2C9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Williamson</last_name>
      <email>eric.williamson@mail.utoronto.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 18, 2021</study_first_submitted>
  <study_first_submitted_qc>April 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Daniel Moore</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

